These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8617758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
    Pokholok DK, Gudima SO, Yesipov DS, Dobrynin VN, Rechinsky VO, Kochetkov SN.
    FEBS Lett; 1993 Jul 05; 325(3):237-41. PubMed ID: 7686510
    [Abstract] [Full Text] [Related]

  • 5. [Studies of the resistance of the human immunodeficiency virus to azidothymidine. I. Kinetic studies of the interaction between reverse transcriptase and a series of its mutant forms with substrates and azidothymidine-5'-trisphosphate].
    Pokholok DK, Gudima SO, Esipov DS, Dobrynin VN, Memelova LV, Rechinskiĭ VO, Kochetkov SN.
    Biokhimiia; 1994 May 05; 59(5):739-47. PubMed ID: 7519060
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS, Geib J, Olsen DB, Stahlhut M, Shafer JA, Kuo LC.
    Biochemistry; 1994 Mar 01; 33(8):2113-20. PubMed ID: 7509634
    [Abstract] [Full Text] [Related]

  • 7. Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
    Im GJ, Tramontano E, Gonzalez CJ, Cheng YC.
    Biochem Pharmacol; 1993 Dec 14; 46(12):2307-13. PubMed ID: 7506027
    [Abstract] [Full Text] [Related]

  • 8. Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.
    Lowe DM, Parmar V, Kemp SD, Larder BA.
    FEBS Lett; 1991 May 06; 282(2):231-4. PubMed ID: 1709876
    [Abstract] [Full Text] [Related]

  • 9. Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants.
    Kim B.
    Methods; 1997 Aug 06; 12(4):318-24. PubMed ID: 9245612
    [Abstract] [Full Text] [Related]

  • 10. Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
    Bakhanashvili M, Hizi A.
    Biochemistry; 1994 Oct 11; 33(40):12222-8. PubMed ID: 7522556
    [Abstract] [Full Text] [Related]

  • 11. Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs.
    Gu Z, Arts EJ, Parniak MA, Wainberg MA.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2760-4. PubMed ID: 7535930
    [Abstract] [Full Text] [Related]

  • 12. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.
    Larder BA, Kemp SD, Purifoy DJ.
    Proc Natl Acad Sci U S A; 1989 Jul 28; 86(13):4803-7. PubMed ID: 2472634
    [Abstract] [Full Text] [Related]

  • 13. A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
    Qari SH, Winters M, Vandamme AM, Merigan T, Heneine W.
    Antivir Ther; 2002 Jun 28; 7(2):131-9. PubMed ID: 12212925
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutagenesis of the Glu-89 residue in human immunodeficiency virus type 1 (HIV-1) and HIV-2 reverse transcriptases: effects on nucleoside analog resistance.
    Song Q, Yang G, Goff SP, Prasad VR.
    J Virol; 1992 Dec 28; 66(12):7568-71. PubMed ID: 1279207
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP.
    Hartl MJ, Kretzschmar B, Frohn A, Nowrouzi A, Rethwilm A, Wöhrl BM.
    Nucleic Acids Res; 2008 Feb 28; 36(3):1009-16. PubMed ID: 18096624
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
    Tisdale M, Schulze T, Larder BA, Moelling K.
    J Gen Virol; 1991 Jan 28; 72 ( Pt 1)():59-66. PubMed ID: 1703563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.